ARS Pharmaceuticals is a commercial pharmaceutical company dedicated to enhancing the lives of patients through innovative solutions. The company is set to launch neffy®, an intranasal epinephrine product designed for individuals experiencing Type I allergic reactions, including those triggered by food, medications, and insect bites, which can lead to life-threatening anaphylaxis. ARS Pharmaceuticals fosters a culture of inclusivity, integrity, and creativity, focusing on developing effective treatments for patients and families affected by serious allergic reactions.